On behalf of Castle Biosciences, we would like to invite you to
attend a scientific advisory dinner on the latest advances in molecular
testing for cutaneous melanoma during the time of the 2016 American Society for Dermatologic Surgery Annual Meeting in New Orleans, Louisiana.
During the advisory dinner, we will discuss newly available data supporting the DecisionDx®-Melanoma test (31-gene expression profile) that utilizes tumor biology to provide an individual risk of melanoma recurrence. The new data will include:
These new data are consistent with previously published, multi-center clinical validation studies that established the accuracy of the GEP test (Gerami et al. Clin Cancer Res 2015 and Gerami et al. JAAD 2015).
The objective of this advisory dinner is to:
If you will already be in New Orleans and wish to attend this program, please start the registration process by clicking on the blue Register button in the bottom right corner. Follow-on detailed instructions will be sent to you following your successful online registration.
If you have any questions, please contact Heather Kippola at firstname.lastname@example.org or (832) 974-1274.
This is an exciting time for advancing prognostic accuracy and improved patient management in melanoma. We hope that you can join us for an engaging and thought-provoking discussion.
Friday, November 11, 2016 6:30 PM - 9:30 PMCentral Time
Emeril's Delmonico1300 St. Charles AvenueNew Orleans, Louisiana 70130
Cvent Online Event Registration Software | Copyright © 2000-2017 Cvent, Inc. All rights reserved.